tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market

Cellectar Biosciences (CLRB) Income Statement

Compare
1,438 Followers

Cellectar Biosciences Income Statement

Last quarter (Q3 2025), Cellectar Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cellectar Biosciences's net income was $-4.44M. See Cellectar Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 51.78M$ 38.96M$ 28.81M$ 24.13M$ 15.29M
Depreciation and Amortization
$ 291.65K$ 192.38K$ 148.44K$ 149.91K$ 207.93K
EBITDA
$ -51.49M$ -38.77M$ -28.67M$ -23.98M$ -14.89M
Operating Income
$ -51.78M$ -38.96M$ -28.81M$ -24.13M$ -15.29M
Other Income/Expenses
$ 7.26M$ -3.87M$ -3.04M$ 8.92K$ 196.18K
Pretax Income
$ -44.52M$ -42.83M$ -31.85M$ -24.12M$ -15.09M
Net Income
$ -44.58M$ -42.77M$ -31.79M$ -24.12M$ -15.09M
Per Share Metrics
Basic EPS
$ -36.52$ -104.99$ -135.18$ -130.35$ -228.55
Diluted EPS
$ -41.89$ -104.99$ -135.18$ -130.35$ -228.55
Weighted Average Shares Outstanding
1.22M 407.38K 235.19K 185.05K 66.04K
Weighted Average Shares Outstanding (Diluted)
1.24M 407.38K 235.19K 185.05K 66.04K
Currency in USD

Cellectar Biosciences Earnings and Revenue History